2011 Final Program

Total Page:16

File Type:pdf, Size:1020Kb

2011 Final Program ISHLT Thirty-First Annual Meeting and Scientific Sessions April13–16, 2011 SANFINAL DIEGOPROGRAM Hilton San Diego Bayfront ISHLT • INTERNATIONALISIILT SOCIETY FOR HEART AND LUNG TRANSPLANTATION INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION A society that includes basic science, 2010-2011 Board Of Directors the failing heart and advanced lung disease HILTON SAN DIEGO BAYFRONT, SAN DIEGO, CALIFORNIA, USA OFFICERS Thirty-First Annual Meeting and Scientific Sessions John Dark, MB, FRCS, President, April 13 – 16, 2011 Freeman Hospital, Newcastle, United Kingdom Lori J. West, MD, DPhil, President-Elect, ISHLT Academy: Core Competencies in University of Alberta, Edmonton, Canada Lung Transplantation James K. Kirklin, MD, Past-President, April 12 – 13, 2011 University of Alabama at Birmingham, AL, USA Duane Davis, MD, Secretary-Treasurer, Duke University Medical Center, Durham, NC, USA DIRECTORS Raymond L. Benza, MD, Allegheny General Hospital, Pittsburgh, PA, USA Susan M. Chernenko, RN, MN, NP, Toronto General Hospital, Toronto, Canada Maria G. Crespo-Leiro, MD, Hospital Universitario A Coruna, La Coruna, Spain James F. George, PhD, University of Alabama at Birmingham, AL, USA Allan R. Glanville, MD, FRACP, St. Vincent’s Hospital, Sydney, Australia Jayan Parameshwar, FRCP, Papworth Hospital, Cambridge, United Kingdom Patricia A. Uber, PharmD, University of Maryland, Baltimore, MD, USA J. David Vega, MD, Emory Clinic, Atlanta, GA, USA Geert M. Verleden, MD, PhD, University Hospital Gasthuisberg, Leuven, Belgium Contents: Florian M. Wagner, MD, University Heart Center Hamburg, Eppendorf, Germany Directors • Committees • Reviewers 1 Andreas O. Zuckermann, MD, University of Vienna, Austria Award Recipients 18 EX OFFICIO BOARD MEMBERS Meeting Highlights • Gala • CME Information 24 Mandeep R. Mehra, MBBS, FACC, FACP, Editor, Journal of Daily Schedule Foldouts between 18-35 Heart and Lung Transplantation, University of Maryland Floorplan Diagrams 36 School of Medicine, Baltimore, MD, USA Marshall I. Hertz, MD, Transplant Registry Medical Director, ISHLT Academy Program 38 University of Minnesota, MN, USA Schedule at a Glance 44 Richard N. Pierson, III, MD, 2011 Scientific Program Chair, Scientific Program 56 University of Maryland-Baltimore, USA Heather J. Ross, MD, MHSc, FRCP(C), Development General Poster Session 143 Committee Chair, Toronto General Hospital, Canada Exhibitor Floorplan and List of Exhibitors 184 Amanda W. Rowe, ISHLT Executive Director Independent Medical Education Activity 210 STAFF Amanda W. Rowe, Executive Director 14673 Midway Road, Suite 200 Phyllis Glenn, Director of Membership Services Lisa A. Edwards, Director of Meetings Addison, Texas 75001 Lee Ann Mills, Director of Operations PHONE: 972-490-9495 FAX: 972-490-9499 Susie Newton, Administrative Assistant www.ishlt.org [email protected] 1 INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION 2011 Annual Meeting 2011 Annual Meeting Scientific Program Committee Abstract Reviewers PROGRAM CHAIR: Richard N. Pierson, III, MD, Keith D. Aaronson, MD, University of Maryland-Baltimore, MD, USA University of Michigan Med Center, Ann Arbor, MI, USA PRESIDENT: John Dark, MB, FRCS, Richa Agarwal, MD, University of Chicago, Chicago, IL, USA Freeman Hospital, Newcastle Upon Tyne, United Kingdom James S. Allan, MD, Mass General Hospital, Boston, MA, USA Annalisa Angelini, MD, University of Padua, Padova, Italy Claus B. Andersen, MD, DMSc, Selim M. Arcasoy, MD, Columbia University, New York, NY, USA Rigshospitalet, Copenhagen, Denmark Christian Benden, MD, James B. Atkinson, MD, PhD, University Hospital Zurich, Zurich, Switzerland Vanderbilt University Medical Center, Nashville, TN, USA Raymond L. Benza, MD, Sharon Augustine, CRNP, Allegheny General Hospital, Pittsburgh, PA, USA University of Maryland, Baltimore, MD, USA Marion Delcroix, MD, Marion Delcroix, Leuven, Belgium Robin Avery, MD, The Cleveland Clinic, Cleveland, OH, USA Juan F. Delgado Jimenez, MD, Agnes M. Azimzadeh, PhD, Hospital Doce de Octubre, Madrid, Spain University of Maryland, Baltimore, MD, USA Daniel F. Dilling, MD, Christopher Barnett, MD, MPH, UCSF, University of California- Loyola University Medical Center, Maywood, IL, USA San Francisco/SFGH, San Francisco, CA, USA James F. George, PhD, Markus J. Barten, MD, PhD, University of Alabama at Birmingham, USA Heart Center Leipzig, Leipzig, Germany Bronwyn J. Levvey, RN, Sharon A. Beer, RN, MSc, University Hospital Birmingham, Grad Dip Clin Ep, Alfred Hospital, Melbourne, Australia Birmingham, United Kingdom Mandeep R. Mehra, MBBS, FACC, FACP, University of Alexandria Berg, RN, Maryland School of Medicine, Baltimore, MD, USA Chldren’s Hospital of Atlanta, Atlanta, GA, USA Francis D. Pagani, MD, PhD, Gerald J. Berry, MD, Stanford University, Stanford, CA, USA University of Michigan Health System, Ann Arbor, MI, USA Nancy P. Blumenthal, CRNP, University of Pennsylvania, Philadelphia, PA, USA Michael G. Petty, PhD(c), RN, CCNS, CNS, University of Minnesota Medical Center, Minneapolis, MN, USA Annette Boehler, MD, University Hospital Zurich, Zurich, Switzerland Evgenij V. Potapov, MD, PhD, German Heart Institute, Berlin, Germany Roberta C. Bogaev, MD, FACC, Texas Heart Institute at St. Luke’s Episcopal Hospital, Houston, TX, USA Hermann Reichenspurner, MD, PhD, University Heart Centre Hamburg Eppendorf, Germany Andrew J. Boyle, MD, Aurora St. Luke’s Medical Center, Milwaukee, WI, USA Marlene Rose, PhD, Harefield Hospital, Harefield, United Kingdom Patrick Bruneval, MD, HEGP, Hopital European Georges Pompidou, Paris, France Bruce R. Rosengard, MD, FRCS, Massachusetts General Hospital, Boston, MA, USA Margaret M. Burke, FRCPath, Harefield Hospital, London, United Kingdom Heather J. Ross, MD, MHSc, FRCP(c), Toronto General Hospital, Toronto, Canada Martin Carby, FRCS (C-R), Harefield Hospital, London, United Kingdom Fernanda P. Silveira, MD, Daniel C. Chambers, MBBS, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA Prince Charles Hospital, Brisbane, Queensland, Australia Lynne W. Stevenson, MD, Cecilia Chaparro, MD, Brigham & Women’s Hospital, Boston, MA, USA Toronto General Hospital, Toronto, Ontario, Canada Stuart C. Sweet, MD, PhD, Clifford Chin, MD, St. Louis Children’s Hospital, St. Louis, MO, USA Stanford Children’s Hospital, Palo Alto, CA, USA Jeffrey J. Teuteberg, MD, Stephen C. Clark, MD, University of Pittsburgh/Presbyterian, Pittsburgh, PA, USA Freeman Hospital, Newcastle Upon Tyne, United Kingdom Vincent G. Valentine, MD, William G. Cotts, MD, University of Texas Medical Branch, Galveston, TX, USA Bluhm Cardiovascular Institute, Chicago, IL, USA Dirk Van Raemdonck, MD, PhD, Jennifer C. Cowger, MD, University Hospital Gasthuisberg, Leuven, Belgium University of Michigan, Ann Arbor, MI, USA Lori J. West, MD, DPhil, Maria M. Crespo, MD, University of Alberta, Edmonton, Canada University of Pittsburgh, Pittsburgh, PA, USA Glen P. Westall, FRACP, PhD, Judy A. Currey, PhD, Alfred/Deakin Nursing Research Center, Alfred Hospital, Melbourne, Australia Melbourne, Victoria, Australia 2 3 ABSTRACT REVIEWERS Lara Danziger-Isakov, MD, MPH, Peter M. Hopkins, FRACP, The Cleveland Clinic Foundation, Cleveland, OH, USA Prince Charles Hospital, Brisbane, Australia Hiroshi Date, MD, Kyoto University, Kyoto, Japan Martin P. Iversen, MD, PhD, Sabina M. De Geest, RN, PhD, Rigshospitalet, Copenhagen, Denmark University of Basel, Basel, Switzerland Valluvan Jeevanandam, MD, Roelof A. de Weger, PhD, University of Chicago Medical Center, Chicago, IL, USA University Medical Center Utrecht, Utrecht, The Netherlands Beth D. Kaufman, MD, Mario C. Deng, MD, Children’s Hospital of Philadelphia, Philadelphia, PA, USA Columbia University Medical Center, New York, NY, USA Cassie C. Kennedy, MD, Mayo Clinic, Rochester, MN, USA Tobias Deuse, MD, PhD, Shaf Keshavjee, MD, FRCSC, University Heart Center Hamburg, Hamburg, Germany Toronto General Hospital, Toronto, Ontario, Canada Gundeep S. Dhillon, MD, Daniel H. Kim, MD, Mazankowski Alberta Heart Institute, Stanford University Medical Center, Stanford, CA, USA Edmonton, Alberta, Canada Lieven J. Dupont, MD, PhD, Richard Kirk, MA FRCP FRCPCH, University Hospital Gasthuisberg, Leuven, Belgium Freeman Hospital, Newcastle Upon Tyne, United Kingdom Thomas M. Egan, MD, MSC, UNC, University of North James K. Kirklin, MD, Carolina School of Medicine, Chapel Hill, NC, USA University of Alabama at Birmingham, Birmingham, AL, USA Stephan M. Ensminger, MD, PhD, Michelle M. Kittleson, MD, PhD, University of Erlangen-Nurnberg, Erlangen, Germany Cedars Sinai Heart Institute, Beverly Hills, CA, USA Michiel E. Erasmus, MD, PhD, University Medical Center Walter Klepetko, MD, Groningen, Groningen, The Netherlands Medical University of Vienna, Vienna, Austria Melanie D. Everitt, MD, Jon Kobashigawa, MD, Primary Children’s Medical Center, Salt Lake City, UT, USA Cedars-Sinai Heart Institute, Beverly Hills, CA, USA Giuseppe Faggian, MD, University of Verona, Verona, Italy Daniel Kreisel, MD, PhD, James C. Fang, MD, Washington University School of Medicine, St. Louis, MO, USA Case Western University Hospital, Shaker Heights, OH, USA Bernard M. Kubak, MD, PhD, Albert Faro, MD, St. Louis Children’s Hospital, Washington UCLA Medical Center, Los Angeles, CA, USA University School of Medicine, St. Louis, MO, USA Michael A. Kuhn, MD, Erika D. Feller, MD, University of Maryland, Baltimore, MD, USA Loma Linda University, Loma Linda, CA, USA Michael C. Fishbein, MD, Renee L. Lassinger,
Recommended publications
  • 2014 FP 1-78:4-Color Section
    FINAL PROGRAM 34th Annual Meeting and Scientific Sessions April 10 – 13, 2014 MANCHESTER GRAND HYATT SAN DIEGO International Society for Heart and Lung Transplantation Gilead is committed to expanding healthcare options for individuals living with cardiovascular and pulmonary diseases through innovative research, access, and education programs. © 2013 Gilead Sciences, Inc. All rights reserved. UNBP0009 March 2013 Gilead and the Gilead logo are trademarks of Gilead Sciences, Inc. INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION 34th ANNUAL MEETING and SCIENTIFIC SESSIONS April 10 – 13, 2014 TABLE OF CONTENTS About ISHLT 2 Board of Directors 4 Scientific Program Committee 6 Abstract Reviewers 8 Committees 17 Scientific Councils 25 Past Presidents 32 Daily Schedule Foldouts between 34-47 Award Recipients 35 Continuing Medical Education 46 Annual Meeting 49 Scientific Session Highlights Manchester Grand Hyatt Floor Plans 64 Annual Meeting 67 Schedule At a Glance Corporate Partners 78 Annual Meeting 79 Scientific Program and Schedule Exhibit Hall Floor Plan 278 List of Exhibitors 280 1 2 THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, educa- tion and advocacy. ISHLT was created in 1981 at a small gathering of The about 15 cardiologists and Purposes cardiac surgeons. Today we of the have over 2700 members from over 45 countries, rep- Society resenting over 15 different are: professional disciplines in- 1. To associate persons volved in the management interested in the fields of heart and treatment of end-stage and lung transplantation, end- heart and lung disease.
    [Show full text]
  • Confirmed Minutes of the London Regional Transfusion
    The London Regional Transfusion Committee Confirmed Minutes of the London Regional Transfusion Committee London Blood Transfusion Forum (RTC Business Meeting) held on 14 October 2016 at The Atrium, Royal Free Hospital Present: Abdul Adamu (AA) Whttington Hospital Anita Aggrey (AAG) Barnet General Hospital Shubha Allard (SA) Barts Health/NHSBT Magda Al-Obaidi (MAO) West Middlesex University Hospital Mariam Ammoun (MA) Hammersmith Hospital Namal Bandara (NB) Kings College Hospital Lorraine Barwick (LB) Great Ormond Street Hospital Chetan Bhatt (CB) Whittington Hospital Dilraj Birdee (DB) Hammersmith Hospital Heather Brotherton (HB) Chase Farm Hospital Alison Brownell (AB) Queens Hospital Romford Elaine Carter-Leay (ECL) Queens Hospital Romford Sandeepa Chandarana (SC) Barnet General Hospital Vashira Chiroma (VC) Hammersmith Hospital Gavin Cho (GC) NHSBT Sarah Clark (SC) Royal Free Hospital Michelle Conway (MC) Harefield Hospital Bernadette Cruz (BC) Northwick Park Hospital Helena Day (HD) Harefield Hospital Ciara Donohue (CD) Royal Free Hospital Oluwatola Elegbe (OE) Barts Health Fernando Fegarido (FF) Kings College Hospital Matthew Free (MF) SWL Pathology - St. George’s Hospital Diana Gabriel (DG) Barts Health Champika Gamlath (CG) Kings College Hospital Lisa Gibb (LG) Great Ormond Street Hospital Jan Gordon (JG) Chelsea & Westminster Hospital Christy Green (CG) Royal London Hospital Jane Harris (JH) New Victoria Hospital Amanda Hobson (AH) Royal Free Hospital Dena Howlett (DH) Epsom General Hospital Charmaine Jardiel (CJ) West Middlesex
    [Show full text]
  • January 22, 2013
    January 22, 2013 Dear Centers for Medicare & Medicaid Services, I am writing to make a formal request for a new national coverage determination (NCD) for the AlloMap gene expression test that is provided by XDx Expression Diagnostics. I am formally requesting that Medicare choose not to pay a reimbursement for this test, which is an inferior diagnostic test. I will make this case using the publically available evidence below. The AlloMap gene test falls under the benefit category: diagnostic test. The AlloMap gene expression test is designed to identify individuals in need of a heart biopsy to identify acute cellular rejection in a heart transplant population. As such, this test is useful in only a small percentage of Medicare patients. It was approved by the FDA (510(k) Number: k073482) in 2008. From the FDA file k073482, the indications for use are as follows: Indication(s) for use: AlloMap Molecular Expression Testing is an In Vitro Diagnostic Multivariate Index assay (IVDMIA) test service, performed in a single laboratory, assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells (PBMC). AlloMap Testing is intended to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (ACR) at the time of testing in conjunction with standard clinical assessment. Indicated for use in heart transplant recipients: • 15 years of age or older • At least 2 months (≥55 days) post-transplant Traditionally, the surveillance of heart transplant recipients for acute cellular rejection (ACR) and antibody mediated rejection (humoral, AMR) has been performed through the interactions of cardiologists and pathologists.
    [Show full text]
  • Studies of ACE-Inhibition and Nitrate Supplementation
    Augmenting Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease: Studies of ACE-inhibition and Nitrate Supplementation Katrina Jane Curtis The Muscle Laboratory, Royal Brompton Hospital National Heart & Lung Institute, Imperial College London Submitted for the degree of Doctor of Philosophy (PhD) Imperial College London 1 Declaration of originality The data present in this thesis are the result of my original work. Where appropriate the contribution made by other persons has been appropriately acknowledged. Statement of contribution Contributions were made by Kawah Li and Professor Hugh Montgomery at University College London, who performed the ACE genotyping. In addition, Magda Minnion and Professor Martin Feelisch at the University of Southampton performed the measurement of the plasma nitrate and nitrite levels. Juliet Polkey provided assistance with the isotime data analysis in the nitrate supplementation work. Victoria Meyrick and Bhavin Mehta led the pulmonary rehabilitation programme at the Royal Brompton Hospital, and the team at Harefield Hospital are also acknowledged for their assistance in this respect. Copyright declaration The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives license. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the license terms of this work. Sources of funding The research in the thesis was funded by the Medical Research Council (grant reference MR/J000620/1) and the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, where it was undertaken.
    [Show full text]
  • FORMATO PDF Ranking Instituciones No Acadã©Micas Por Sub áRea
    Ranking Instituciones No Académicas por sub área OCDE 2020 6. Humanidades > 6.03 Filosofía, Ética y Religión PAÍS INSTITUCIÓN RANKING PUNTAJE FRANCE Centre National de la Recherche Scientifique (CNRS) 1 5,000 RUSSIA Russian Academy of Sciences 2 5,000 USA National Institutes of Health (NIH) - USA 3 5,000 RUSSIA Institute of Philosophy, Russian Academy of Sciences 4 5,000 SPAIN Consejo Superior de Investigaciones Cientificas (CSIC) 5 5,000 USA Seattle Children's Hospital 6 5,000 USA NIH Clinical Center (CC) 7 5,000 USA VA Boston Healthcare System 8 5,000 SLOVAKIA Slovak Academy of Sciences 9 5,000 ARGENTINA Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) 10 5,000 SPAIN CSIC - Instituto de Lenguas y Culturas del Mediterraneo y Oriente Proximo (ILC) 11 5,000 NETHERLANDS Erasmus University Medical Center 12 5,000 NETHERLANDS Academic Medical Center Amsterdam 13 5,000 USA Harvard School of Dental Medicine 14 5,000 GERMANY Helmholtz Association 15 5,000 USA University of Illinois Chicago Hospital 16 5,000 USA Mayo Clinic 17 5,000 FRANCE CNRS - Institute for Humanities & Social Sciences (INSHS) 18 5,000 GERMANY Max Planck Society 19 5,000 AUSTRALIA Florey Institute of Neuroscience & Mental Health 20 5,000 USA The World Bank 21 5,000 CZECH REPUBLIC Czech Academy of Sciences 22 5,000 USA NIH National Institute of Environmental Health Sciences (NIEHS) 23 5,000 NETHERLANDS VU UNIVERSITY MEDICAL CENTER 24 5,000 FRANCE Institut National de la Sante et de la Recherche Medicale (Inserm) 25 5,000 NETHERLANDS Utrecht University Medical
    [Show full text]
  • The Royal Brompton & Harefield Hospital NHS Foundation Trust
    The Royal Brompton & Harefield Hospital NHS Foundation Trust Royal Brompton Hospital Congenital Heart Disease Network 2019 / 20 Annual Business Plan Authors: Dr Nitha Naqvi Dr Leonie Wong Lawrence Mack Simon Boote Approved by: Congenital Heart Disease Working Group Ratification Committee: Congenital Heart Disease Network Board Date Ratified: 29/04/2019 Chairman: Dr Angela Tillett Implemented by: All Document Authors Meeting Chair Meeting Members Network Management Team Issue Date: April 2019 Version: 001 Review Date: March 2020 Review interval: 12 Months Issued: April 2019 Version: 001 Page | 1 Contents Page Link 1 Contents 1 Contents ................................................................................................................................................................... 2 2 The Brompton Hospital and Congenital Heart Disease ................................................................................... 3 3 The Annual Business Plan .................................................................................................................................... 3 4 Governance & Committee Structure ................................................................................................................... 3 5 RBH-CHD Strategic Vision ................................................................................................................................... 4 6 Operational Delivery Network ..............................................................................................................................
    [Show full text]
  • Publish Date: July 2015 Volume 1, Issue 2
    Publish Date: July 2015 Volume 1, Issue 2 OFFICIAL JOURNAL OF THE PICS FOUNDATION Published by Now accepting papers at http://structuralheartdisease.org ISSN 2325-4637 Editorial Board Editor-in-Chief Associate Editors Ziyad M. Hijazi Sidra Medical & Research Center Clifford J. Kavinsky Rush University Medical Center (Doha-qatar) (Chicago, IL) Bray Patrick Lake PFO Research Foundation Co-Editor-in-Chief (Boulder, CO) John Messenger University of Colorado Horst Sievert CardioVascular Center (Aurora, CO) Sankt Katharinen Hospital (Frankfurt, Germany) Managing Editor Hussam Suradi Rush University Medical Center Assistant Editors (Chicago, IL) Damien Kenny Rush University Medical Center (Chicago, IL) Michael Kim University of Colorado (Aurora, CO) Editorial Board Teiji Akagi Okayama University Roberto Cubeddu Aventura Hospital (Okayama, Japan) (Miami, FL) Bagrat Alekyan Bakoulev Scientific Center for Bharat Dalvi Glenmark Cardiac Centre Cardiovascular Surgery (Mumbai, India)Jo De Giovanni (Moscow, Russia) Birmingham Children’s Hospital Zahid Amin Children’s Hospital of Georgia (Birmingham, United Kingdom) (Augusta, GA) Helene Eltchanninof University Hospital Vasilis Babaliaros Emory University (Rouen, France) (Atlanta, GA) Maiy El Syed Ain Shams Univesity Steven Bailey University of Texas, San Antonio (Cairo, Egypt) (San Antonio, TX) Thomas Fagan University of Colorado Lee Benson Hospital for Sick Kids (Denver, CO) (Toronto, Canada) Ted Feldman Evanston Northshore Hospital Lisa Bergersen Boston Children’s Hospital (Evanston, IL) (Boston, MA)
    [Show full text]
  • 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines
    2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation Sharon Ann Hunt, William T. Abraham, Marshall H. Chin, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Mariell Jessup, Marvin A. Konstam, Donna M. Mancini, Keith Michl, John A. Oates, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, and Clyde W. Yancy J. Am. Coll. Cardiol. 2009;53;e1-e90; originally published online Mar 26, 2009; doi:10.1016/j.jacc.2008.11.013 This information is current as of April 20, 2009 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://content.onlinejacc.org/cgi/content/full/53/15/e1 Downloaded from content.onlinejacc.org by on April 20, 2009 Journal of the American College of Cardiology Vol. 53, No. 15, 2009 © 2009 by the American College of Cardiology Foundation and the American Heart Association, Inc. ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.11.013 PRACTICE GUIDELINE: FULL TEXT 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation 2005 Writing Sharon Ann Hunt, MD, FACC, FAHA, Chair Marvin A.
    [Show full text]
  • ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery
    © 2004 by the American College of Cardiology Foundation and the American Heart Association, Inc. ACC/AHA PRACTICE GUIDELINES—FULL TEXT ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) Developed in Collaboration With the American Association for Thoracic Surgery and the Society of Thoracic Surgeons WRITING COMMITTEE MEMBERS Kim A. Eagle, MD, FACC, FAHA, Co-chair Robert A. Guyton, MD, FACC, FAHA, Co-chair Ravin Davidoff, MB, BCh, FACC, FAHA L. David Hillis, MD, FACC Fred H. Edwards, MD, FACC, FAHA Adolph M. Hutter, Jr., MD, MACC, FAHA Gordon A. Ewy, MD, FACC, FAHA Bruce Whitney Lytle, MD, FACC Timothy J. Gardner, MD, FACC, FAHA Robert A. Marlow, MD, MA, FAAFP James C. Hart, MD, FACC William C. Nugent, MD Howard C. Herrmann, MD, FACC, FAHA Thomas A. Orszulak, MD, FACC TASK FORCE MEMBERS Elliott M. Antman, MD, FACC, FAHA, Chair Sidney C. Smith, Jr., MD, FACC, FAHA, Vice Chair Joseph S. Alpert, MD, FACC, FAHA† Gabriel Gregoratos, MD, FACC, FAHA† Jeffrey L. Anderson, MD, FACC, FAHA Jonathan L. Halperin, MD, FACC, FAHA David P. Faxon, MD, FACC, FAHA Loren F. Hiratzka, MD, FACC, FAHA Valentin Fuster, MD, PhD FACC, FAHA Sharon Ann Hunt, MD, FACC, FAHA Raymond J. Gibbons, MD, FACC, FAHA†‡ Alice K. Jacobs, MD, FACC, FAHA Joseph P. Ornato, MD, FACC, FAHA †Former Task Force Member (specify version and reprint number): Up to 999 copies, call 1-800-611-6083 ‡Immediate Past Chair (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1789, fax 214-691-6342, or e-mail [email protected].
    [Show full text]
  • News · Case Studies · Insights from Royal Brompton & Harefield
    Case Notes News · Case Studies · Insights From Royal Brompton & Harefield Hospitals · London International Edition 2020 Welcome to the International Edition 2020 of Case Notes Contents At Royal Brompton & Harefield Hospitals Specialist Care, private patients can access the highest quality diagnostics, treatment and care for heart and lung conditions. We are based in three convenient London locations – Royal Brompton Hospital in Chelsea, Harefield Hospital in Middlesex and 77 Wimpole Street in the Harley Street Medical Area. I am delighted to share with you our latest news and a range of articles to A life-saving alternative showcase the knowledge and skills treatment for faulty heart valves of our incredible team of expert PAGE 6 consultants and specialists. David Shrimpton The RB&HH transcatheter valve Managing Director, service provides access to alternative RB&HH Specialist Care life-saving treatments for faulty heart valves. Find out about the TAVI procedure led by Dr Simon Davies, and the most experienced MitraClip Improved quality of life with MitraClip therapy therapy service in the UK led by Dr PAGE 8 Robert Smith. Furthermore, discover the latest treatment for calcified coronary What's new? arteries using intravascular lithotrispy. PAGE 2 Revolutionary technique If you have any questions about our avoids numerous surgeries services, or you would like to refer for heart patients a patient, please get in touch – we would be delighted to hear from you. World-class care across PAGE 14 three London locations PAGE 4 Minimally invasive
    [Show full text]
  • 2008 Final Program
    BOARD OF DIRECTORS President Paul A. Corris, MB, FRCP, Newcastle, United Kingdom Past President Robert C. Robbins, MD, Stanford, CA President-Elect Mandeep R. Mehra, MD, Baltimore, MD Secretary-Treasurer Heather J. Ross, MD, FRCPC, MHSC, Toronto, Canada DIRECTORS Nicholas R. Banner, FRCP, Harefield, United Kingdom Duane Davis, MD, Durham, NC Fabienne Dobbels, PhD, Leuven, Belgium Roger W. Evans, PhD, Rochester, MN Mariell Jessup, MD, Philadelphia, PA Shaf Keshavjee, MD, FRCSC, FACS, Toronto, Canada Joren C. Madsen, MD, DPhil, Boston, MA Bruno M. Meiser, MD, Munich, Germany Takeshi Nakatani, MD, PhD, Osaka, Japan Randall C. Starling, MD, MPH, Cleveland, OH Stuart C. Sweet, MD, PhD, St. Louis, MO EX OFFICIO BOARD MEMBERS JHLT Editor James K. Kirklin, MD, Birmingham AL Transplant Registry Medical Director Marshall I. Hertz, MD, Minneapolis, MN Scientific Program Chair Lori J. West, MD, DPhil, Edmonton, Canada Staff Amanda W. Rowe Executive Director Phyllis Glenn Director of Membership Services Lisa Edwards Director of Meetings Lee Ann Mills Director of Operations Susie Newton Administrative Assistant 14673 Midway Road, Suite 200 Addison, TX 75001 Phone: 972-490-9495 Fax: 972-490-9499 www.ishlt.org [email protected] SCIENTIFIC PROGRAM COMMITTEE Lori J. West, MD, DPhil, Edmonton, Canada, Program Chair Paul A. Corris, MB FRCP, Newcastle, United Kingdom, President Mark L. Barr, MD, Los Angeles , CA Michael Burch, MD, London, United Kingdom Michael Chan, MD, FRCPC, Edmonton, Canada Susan M. Chernenko, MN, Toronto, Canada Jason D. Christie, MD, Philadelphia, PA Duane Davis, MD, Durham, NC Roelof A. De Weger, PhD, Utrecht, The Netherlands Thomas G. DiSalvo, MD, Nashville, TN Howard J.
    [Show full text]
  • National Cardiac Arrest Audit Participating Hospitals List England
    Updated January 2015 National Cardiac Arrest Audit Participating hospitals list The total number of hospitals signed up to participate in NCAA is 181. England Birmingham and Black Country Non-participant Hereford County Hospital Wye Valley NHS Trust New Cross Hospital The Royal Wolverhampton Hospitals NHS Trust Queen Elizabeth Hospital, Birmingham University Hospital Birmingham NHS Foundation Trust Participant Alexandra Hospital Worcestershire Acute Hospitals NHS Trust Birmingham Heartlands Hospital Heart of England NHS Foundation Trust City Hospital Sandwell and West Birmingham Hospitals NHS Trust Good Hope Hospital Heart of England NHS Foundation Trust Manor Hospital Walsall Healthcare NHS Trust Russells Hall Hospital The Dudley Group of Hospitals NHS Trust Sandwell General Hospital Sandwell and West Birmingham Hospitals NHS Trust Solihull Hospital Heart of England NHS Foundation Trust Worcestershire Royal Hospital Worcestershire Acute Hospitals NHS Trust Central England Non-participant George Eliot Hospital George Eliot Hospital NHS Trust University Hospital Coventry University Hospitals Coventry and Warwickshire NHS Trust Participant Glenfield Hospital University Hospitals of Leicester NHS Trust Kettering General Hospital Kettering General Hospital NHS Foundation Trust Leicester General Hospital University Hospitals of Leicester NHS Trust Leicester Royal Infirmary University Hospitals of Leicester NHS Trust Northampton General Hospital Northampton General Hospital NHS Trust Warwick Hospital South Warwickshire NHS Foundation Trust
    [Show full text]